Colonial Trust’s Bristol-Myers Squibb BMY Stock Holding History

Colonial Trust’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$532K	Sell	8,769 -30	-0.3%	-$1.75K	0.07%	176
2025 Q4	$475K	Sell	8,799 -205	-2%	-$9.86K	0.06%	191
2025 Q3	$406K	Sell	9,004 -233	-3%	-$10.9K	0.05%	214
2025 Q2	$428K	Buy	9,237 +23	+0.2%	+$1.13K	0.06%	199
2025 Q1	$562K	Sell	9,214 -803	-8%	-$46.8K	0.09%	157
2024 Q4	$567K	Sell	10,017 -2,978	-23%	-$166K	0.08%	163
2024 Q3	$672K	Buy	12,995 +2,961	+30%	+$139K	0.1%	152
2024 Q2	$417K	Sell	10,034 -135	-1%	-$6.04K	0.07%	169
2024 Q1	$551K	Buy	10,169 +147	+1%	+$7.49K	0.1%	141
2023 Q4	$514K	Sell	10,022 -325	-3%	-$17.1K	0.11%	142
2023 Q3	$601K	Sell	10,347 -300	-3%	-$18.4K	0.15%	118
2023 Q2	$681K	Sell	10,647 -741	-7%	-$49.7K	0.16%	111
2023 Q1	$789K	Sell	11,388 -404	-3%	-$28.5K	0.2%	96
2022 Q4	$848K	Sell	11,792 -1,150	-9%	-$86.7K	0.23%	90
2022 Q3	$920K	Buy	+12,942	New	+$939K	0.29%	83

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Colonial Trust's BMY Position: Q1 2026 in Review

Colonial Trust reduced its Bristol-Myers Squibb (BMY) stake by 0.34% in Q1 2026, selling an estimated $1.75K and leaving 8,769 shares worth $532K. The position accounts for 0.07% of the portfolio, ranked #176.

Colonial Trust first reported a position in BMY in Q3 2022 and has held it in 15 quarters since. The position peaked at $920K in Q3 2022. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Colonial Trust held 8,769 shares of Bristol-Myers Squibb worth $532K as of Q1 2026.
Colonial Trust sold 30 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.75K.
Bristol-Myers Squibb made up 0.07% of Colonial Trust's portfolio in Q1 2026, its #176 holding.
Colonial Trust first reported a position in Bristol-Myers Squibb in Q3 2022 and has held it in 15 quarters since.
Colonial Trust's Bristol-Myers Squibb position peaked at $920K in Q3 2022.
2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Colonial Trust's 13F filing for Q1 2026, filed 12 May 2026.